Saturday, July 20, 2019

Pharmaceutical Industry Study Focuses on Using Medical Affairs to Improve Payer Interactions

In the wake of the rising influence of public and private payers, pharmaceutical companies are seeking more effective ways to work with payer organizations. In particular, pharma is turning to the medical affairs function to...

Enhanced Healthcare Partners Announces Investment in SCA Pharmaceuticals

Enhanced Healthcare Partners ("EHP"), a private equity firm focused exclusively on investing in the healthcare industry, has announced its investment in SCA Pharmaceuticals ("SCA"), a sterile compounding leader specializing in preparing sterile pharmaceuticals...

EDGC to Launch Liquid Biopsy Screening Service, Technology for Early Detection of Cancers, This...

Liquid biopsy drawing attention for preventing the recurrence of cancer and allowing for early detection of cancers EDGC develops the most advanced lipuid biopsy technology EONE-DIAGNOMICS Genome Center (EDGC), a global company in genetic analysis, has announced the...

Aralez Pharmaceuticals To Enter Into Purchase Agreements To Sell Substantially All Assets

Company to Continue Operating Business and Serving Customers As Usual Aralez Pharmaceuticals Inc. announced today that it intends to enter into purchase agreements with two separate stalking-horse purchasers to sell its main operating businesses:  an...

Thermo Fisher Scientific Opens New Bioprocess Design Center in Shanghai

Facility enables customer collaboration to optimize bioprocessing solutions Thermo Fisher Scientific, the world leader in serving science, today opened its first Bioprocess Design Center in Shanghai, China. The new center is part of a strategy to...

RWS Expands Global Offering with RWS Life Sciences

The acquisition of LUZ, Inc. and Corporate Translations, Inc. strengthens RWS' market leadership and continued growth of life science language services On October 1, 2017 RWS, the world's leading provider of translation, intellectual property, life sciences...

Lilly Announces Agreement To Acquire ARMO BioSciences

.6 billion transaction will bolster Lilly's clinical portfolio with ARMO's lead immuno-oncology asset, pegilodecakin, which is being studied in multiple tumor types Eli Lilly and Company and ARMO BioSciences, Inc. today announced a definitive agreement...

Alcami Announces Industry-Leading Analytical Testing Turnaround Time

Alcami Corporation, a leading provider of fully-integrated custom end-to-end solutions for the pharmaceutical and biotechnology industries, today announces the advancement of the drug development process with the company's new, dramatically-reduced analytical testing turnaround...

Alzheimer’s Disease: Cannabis Formulation Shows Promise

Known as America's most expensive disease, with an estimated cost to the U.S. economy of 6 billion in 2016, Alzheimer's disease (AD) affects more than 5.3 million Americans. Over the next 20 years, the number of...

Virtual Reality in Medicine and Healthcare to Generate US$285 million in 2022

Therapy and Training Services have the highest opportunity in VR medical and healthcare segment Virtual Reality (VR) has brought a range of new services into the healthcare industry.  The immersive experience provided by VR...

Connect with us

4,475FansLike
1,007FollowersFollow
12,053FollowersFollow

Popular Posts